Sign In
Buy IQV
$182.05
+1.41 (+0.781%)
At Close: Jun 03, 2026
IQVIA Holdings (IQV) Q2 Earnings and Revenues Surpass Estimates
09:15am, Monday, 22'nd Jul 2024
IQVIA Holdings (IQV) came out with quarterly earnings of $2.64 per share, beating the Zacks Consensus Estimate of $2.58 per share. This compares to earnings of $2.43 per share a year ago.
IQVIA raises annual profit forecast on improving demand for analytics services
09:07am, Monday, 22'nd Jul 2024
Contract research firm IQVIA Holdings raised its forecast for full-year profit on Monday, banking on strength in demand for its healthcare data and analytics services.
IQVIA Reports Second-Quarter 2024 Results
07:00am, Monday, 22'nd Jul 2024
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to th
IQVIA (IQV) to Report Q2 Earnings: What's in the Offing?
12:00pm, Wednesday, 17'th Jul 2024
IQVIA's (IQV) second-quarter 2024 revenues are likely to have gained from growth in the Technology and Analytics, and Research and Development segments.
Clinical Development Expertise Aids IQVIA (IQV), Costs High
09:05am, Monday, 01'st Jul 2024
IQVIA (IQV) benefits from its healthcare-specific global IT infrastructure and domain expertise to expand and penetrate different markets.
IQVIA's SmartSolve® eQMS Wins 2024 MedTech Breakthrough Award “Best Use of Artificial Intelligence in Healthcare”
08:00am, Tuesday, 25'th Jun 2024
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a leading global provider of AI-powered analytics, technology solutions, and clinical research services to the life sciences industr
IQVIA (IQV) Announces Launch of Trial Technology Platform
02:07pm, Thursday, 13'th Jun 2024
IQVIA's (IQV) One Home for Sites allows pharmaceutical companies and their software vendors to streamline clinical application management.
IQVIA Launches “One Home” Clinical Trial Technology Platform – Solves Challenges and Reduces Overload at Sites
08:00am, Wednesday, 12'th Jun 2024
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV) today announced the launch of One Home for Sites™, a new technology platform that acts as a single sign-on and a single dashboard for
IQVIA Institute: Innovative Therapies and Strong Pipeline to Combat Rise in Cancer Diagnoses
08:00am, Monday, 10'th Jun 2024
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--As cancer incidence continues to rise, it's being met by wider use of innovative therapies and a robust pipeline of new drugs, according to a new report
Final Trades: Amazon, Goldman Sachs, AbbVie and IQVIA Holdings
02:32pm, Thursday, 06'th Jun 2024
The Investment Committee give you their top stocks to watch for the second half.
IQVIA: Long-Term Compounder Throwing Off Free Cash Flow
03:57pm, Monday, 27'th May 2024
There have been numerous positive updates to IQVIA Holdings' fundamental economics since January 2023. It produced strong Q1 2024 earnings, with growth observed in all segments. Increasing returns fro
Here's Why You Should Hold on to IQVIA (IQV) Stock for Now
12:20pm, Friday, 24'th May 2024
IQVIA (IQV) benefits from a powerful healthcare-specific global IT infrastructure and a robust real-world solutions ecosystem. However, high operating expenses are a headwind.
U.S. Medicines Spending Grew in 2023 as Greater Access Offset COVID-19-related Decline, Says IQVIA Institute
08:00am, Tuesday, 14'th May 2024
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Overall spending in the U.S. market for medicines grew by 2.5% and reached $435Bn in 2023. Excluding the contribution from COVID-19 vaccines and therapeu
IQVIA CFO Ron Bruehlman to Speak at the Bank of America Health Care Conference on May 14, 2024
04:15pm, Thursday, 09'th May 2024
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the
Here's Why IQVIA Holdings (IQV) is a Strong Value Stock
10:46am, Friday, 03'rd May 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
